Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Novel BTK Degraders for Refractory Lymphoma: Targeting Catalytic and Allosteric Sites
Zhou, J. (PI)
Cancer Prevention and Research Institute ( Award #RP250477)
6/1/25 → 5/31/27
Project: Research project
-
Small Compound Inhibitors Targeting HPV Genome Replication
Zhou, J. (PI)
University of Texas SouthWestern Med Cen ( Award #5R01CA28874302)
12/1/24 → 11/30/26
Project: Research project
-
Development of novel BTK-MALT1 dual inhibitors to treat MCL
Zhou, J. (PI)
University of Texas MD Anderson Cancer Center ( Award # )
7/1/23 → 6/30/27
Project: Research project
-
5-HT2 Receptor Allosterism in Cocaine Use Disorder
Zhou, J. (PI)
National Institute on Drug Abuse ( Award #5R01DA03844610)
8/1/22 → 4/30/27
Project: Research project
-
Targeting chemoresistant prostate cancer with novel EED inhibitors
Zhou, J. (PI)
Clark Atlanta University ( Award #5R01CA25605804)
4/1/22 → 3/31/27
Project: Research project
-
Artificial intelligence revolutionizing CNS drug discovery and development
Talukder, M. E. K., Islam, M. R., Ali, S., Zhou, J. & Bolinger, A., May 2026, In: Drug Discovery Today. 31, 3, 104667.Research output: Contribution to journal › Review article › peer-review
-
Correction: The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma (Experimental Hematology & Oncology, (2024), 13, 1, (14), 10.1186/s40164-024-00484-9)
Yan, F., Jiang, V., Jordan, A., Che, Y., Liu, Y., Cai, Q., Xue, Y., Li, Y., McIntosh, J., Chen, Z., Vargas, J., Nie, L., Yao, Y., Lee, H. H., Wang, W., Bigcal, J. N. R., Badillo, M., Meena, J., Flowers, C. & Zhou, J. & 3 others, , Feb 11 2026, In: Experimental Hematology and Oncology. 15, 1, p. 19 19.Research output: Contribution to journal › Article › peer-review
Open Access -
CVN-424: An Advanced GPR6 Inverse Agonist in Phase III Clinical Trials for Parkinson's Disease
Tian, X., Ali, S., Allen, J. & Zhou, J., Apr 9 2026, In: Journal of Medicinal Chemistry. 69, 7, p. 7507-7511 4 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Discovery of small molecules and a druggable groove that regulate DNA binding and release of the AP-1 transcription factor ΔFOSB
McNeme, S., Yim, Y. Y., Kumar, A., Li, Y., Hughes, B., St Romain, C. P., Aglyamova, G., Chen, J., Nguyen, N. D., Fan, S., Stephens, G. S., Zhao, W. N., Kruzshak, S., Estill, M., Brener, C., Tofani, S., Kumar, A., Chen, E. P., Takatka, N. & Robison, A. J. & 9 others, , Feb 2026, In: Journal of Biological Chemistry. 302, 2, 111080.Research output: Contribution to journal › Article › peer-review
Open Access -
Drug Discovery of Antiviral Inhibitors Targeting Dengue Virus NS4B Protein
Pang, S., Qiu, X., Cai, Z., Zhong, Z., Jiang, H., Zhou, J. & Xu, J., May 8 2026, In: ACS Infectious Diseases. 12, 5, p. 1555-1571 17 p.Research output: Contribution to journal › Review article › peer-review